CFO transition

Xponential Fitness, Inc. CFO transition: Jennifer Ryu to succeed Robert Julian

Xponential Fitness, Inc. reported in a Form 8-K filed September 8, 2026 that Jennifer Ryu will succeed Robert Julian as Chief Financial Officer, effective October 19, 2026.

In the filing's words

On September 8, 2026, Xponential Fitness, Inc. (the “Company”) announced the appointment of Jennifer Ryu as the Chief Financial Officer of the Company, effective as of October 19, 2026. Ms. Ryu succeeds Robert Julian, who has served as interim Chief Financial Officer of the Company since March 2026.

Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.

CompanyXponential Fitness, Inc. (XPOF)
EventTransition
IncomingJennifer Ryu
OutgoingRobert Julian
Title in the filingChief Financial Officer
EffectiveOctober 19, 2026
8-K filedSeptember 8, 2026
Internal promotionNot established by the source
SEC CIK0001802156

Xponential Fitness, Inc. reported this change in a Form 8-K, Item 5.02, filed September 8, 2026. The filing's own words are quoted above.

Other records naming Jennifer Ryu

2

The incoming officer on this record, matched by name. Career line.

7 weeks ago· 2026-09-21InterimRGP

Resources Connection, Inc. names Jessica Block interim CFO

2026-07-24 · 10-K signature

Jennifer Ryu signed Resources Connection, Inc.'s annual report as Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

Also filed in September 2026

Other CFO moves on the record that month. All moves.

6 weeks ago· 2026-09-30InterimACI

Albertsons Companies, Inc. names Cody Perdue interim CFO

6 weeks ago· 2026-09-30DepartureALDA

Atlantica Inc. discloses CFO departure: Shelley Goff

6 weeks ago· 2026-09-30TransitionCARL

Carlsmed, Inc. CFO transition: Richard Heppenstall to succeed Leo Greenstein

6 weeks ago· 2026-09-30AppointmentLEVI

Levi Strauss & Co. appoints John Vandemore as CFO

6 weeks ago· 2026-09-30DeparturePTPI

Petros Pharmaceuticals, Inc. discloses CFO departure: Robert Weinstein

6 weeks ago· 2026-09-30DepartureTCRX

TScan Therapeutics, Inc. discloses CFO departure: Jason A. Amello

Sources

  • sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26

Something wrong about Jennifer Ryu? Send a correction with the primary source.